How to define reference intervals to rule in healthy individuals for clinical trials?

Elzen, W.P.J. den; Gerven, J. van; Schenk, P.W.; Boogaard, A.U. den; Kroon, R.; Klaassen, E.; ... ; Cobbaert, C.M. (2017)

Article / Letter to editor

• flagging rates
• reference range
• selecting healthy volunteers for clinical trials

• All authors: Elzen, W.P.J. den; Gerven, J. van; Schenk, P.W.; Boogaard, A.U. den; Kroon, R.; Klaassen, E.; Ballieux, B.E.P.B.; Cobbaert, C.M.
• Date: 2017-03-31
• Journal: Clinical Chemistry and Laboratory Medicine (CCLM)
• Volume: 55
• Issue: 3
• Pages: E59 - E61
• DOI: doi:10.1515/cclm-2016-0307